Speaker illustration

Professor Chim Choy Lang

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology and Head of the Division of Molecular and Clinical Medicine at University of Dundee. He trained in both cardiology and clinical pharmacology in the UK and in the USA, where he was a Merck Fellow at Vanderbilt University, Nashville, and a Fulbright Scholar at Columbia University, New York. His patient-oriented research takes a multidisciplinary approach to the understanding of the pathophysiology of heart failure and cardio-metabolic diseases. He leads an integrated cardiovascular research laboratory dedicated to translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases.

Peripheral neuropathy and increased risk of heart failure: a population-based longitudinal cohort study

Event: ESC CONGRESS 2019

Topic: Comorbidities

Session: Glucose abnormalities and left ventricular dysfunction


Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM

Event: ESC Congress 2018

Topic: Left Ventricular Remodelling

Session: There is no sweet spot in diabetes


MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients

Event: ESC Congress 2018

Topic: Antidiabetic Pharmacotherapy

Session: Cardiac patients with comorbidities


Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment


A ten year observational study on surveillance and incidence of cardiotoxicity in breast cancer therapy

Event: ESC CONGRESS 2016

Topic: Cardiotoxicity of drugs

Session: Cancer and cardiotoxicity: from bench to bedside


ESC 365 is supported by

logo Novo Nordisk